GLMD (Galmed Pharmaceuticals) Beginning Cash Position: $3.44 Mil (As of Dec. 2025)


GLMD Galmed Pharmaceuticals Ltd GLMD
29 GF Score
Price $0.57
! 2 Warning Signs
View Full Analysis

What is Galmed Pharmaceuticals Beginning Cash Position?

Galmed Pharmaceuticals GLMD -11.95% 29 Beginning Cash Position is $3.44 Mil as of Dec. 2025. GuruFocus rates GLMD with a GF Score™ of 29/100. The stock has 2 warning signs investors should review.

Galmed Pharmaceuticals's Beginning Cash Position for the quarter that ended in Dec. 2025 was $3.44 Mil.

Galmed Pharmaceuticals's quarterly Beginning Cash Position increased from Jun. 2025 ($4.89 Mil) to Sep. 2025 ($5.09 Mil) but then declined from Sep. 2025 ($5.09 Mil) to Dec. 2025 ($3.44 Mil).

Galmed Pharmaceuticals's annual Beginning Cash Position increased from Dec. 2023 ($2.13 Mil) to Dec. 2024 ($2.98 Mil) and increased from Dec. 2024 ($2.98 Mil) to Dec. 2025 ($4.77 Mil).

Galmed Pharmaceuticals Beginning Cash Position Related Terms

Galmed Pharmaceuticals Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Galmed Pharmaceuticals's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Galmed Pharmaceuticals Beginning Cash Position Chart

Galmed Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.06 3.00 2.13 2.98 4.77

Galmed Pharmaceuticals Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.13 4.77 4.89 5.09 3.44
GLMD
29GF Score
Galmed Pharmaceuticals Ltd GLMD
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Galmed Pharmaceuticals Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $3.44 Mil mean?
Galmed Pharmaceuticals (GLMD) has a Beginning Cash Position of $3.44 Mil as of Dec. 2025. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Galmed Pharmaceuticals and its competitors.
Is Galmed Pharmaceuticals' Beginning Cash Position too high?
Galmed Pharmaceuticals' current Beginning Cash Position is $3.44 Mil. Overall, Galmed Pharmaceuticals has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Galmed Pharmaceuticals' Beginning Cash Position compare to FBLG and SXTP?
Galmed Pharmaceuticals' Beginning Cash Position of $3.44 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Galmed Pharmaceuticals and its competitors. Galmed Pharmaceuticals's current Beginning Cash Position is $3.44 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galmed Pharmaceuticals stock overvalued right now?
Galmed Pharmaceuticals (GLMD) has a current Beginning Cash Position of $3.44 Mil. The current Beginning Cash Position is $3.44 Mil. Galmed Pharmaceuticals' overall GF Score™ is 29/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Galmed Pharmaceuticals (GLMD), the current Beginning Cash Position is $3.44 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Galmed Pharmaceuticals Business Description

Address c/o Meitar Law Offices, 16 Abba Hillel Road, Ramat Gan, ISR, 5250608
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. The company focuses on the development of Aramchol for combination therapy for GI oncological indications. The company is actively pursuing opportunities in the biotech and medtech spaces to expand and diversify its product pipeline targeting GI, cardiometabolic indications and other product candidates.
29GF Score

Get the complete analysis for GLMD

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.57
Price